.png)
.png)
Latest news from BIA
CEO Update | 6 February 2023
Thank you for your ongoing support for our SME R&D tax relief campaign highlighting the negative impact of the relief rate changes announced in the Autumn Statement for biotech. Thanks to our combined efforts, the Chancellor has said he sees 'merit to the case for further support' for 'R&D intensive businesses'. This is great news, but the devil will be in the detail, so we need your help. Please complete our survey.
World Cancer Day: Meet Infinitopes
For World Cancer Day this weekend, we spoke with Dr Jonathan Kwok, CEO of Infinitopes, a Cancer Research UK (CRUK)-led precision immunology spinout from Oxford University. Dr Kwok describes the challenges of creating novel targeted treatments for cancer, overcoming difficult financial markets, and the importance of working with a passionate team. Infinitopes is also recruiting…
National Apprenticeship Week: Lara's journey to gaining 'Skills for Life'
It's National Apprenticeship Week! This week (6-12 February) we're celebrating everything apprenticeships, with the 2023 #NAW theme being 'Skills for Life'. We spoke to Lara Devenish, Quality Control Associate Scientist at Autolus. Following her sixth-form studies, she joined Autolus as an apprentice where she obtained her foundation degree and bachelor's degree in bioscience. Please continue reading to learn about her experience as an apprentice.
CEO Update | 30 January 2023
The end of January is always incredibly busy at the BIA, with our first Board meeting of the year welcoming newly elected members, the publication of our annual report into the financing of the sector and of course our Gala Dinner which was a great evening last week. Read more on R&D tax credit campaign at centre of finance work, the Chancellors’ growth speech and more.
Complement Therapeutics enrols first patient in non-interventional i-GAIN study of people diagnosed with geographic atrophy
Complement Therapeutics Ltd (CTx), a preclinical stage biotechnology company, today announced enrolment of the first patient in a natural history study of people who have been diagnosed with geographic atrophy (GA).
ACROBiosystems announces the start of its recombinant antibody services
ACROBiosystems has now officially begun its recombinant antibody services which includes comprehensive services encompassing gene construction, expression, purification and quality inspection.
Coulter Partners places three Board Directors at Our Future Health Trading Ltd
Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health, and Tech, recently partnered with Our Future Health Trading Ltd, and is pleased to announce the placements of Cristina Ortega Duran, Andy Richards and Simon Sturge as Board Directors.
Imperial startup Biocentis to develop genetic tech to control harmful insects
Biocentis has received investment to use CRISPR-based gene-editing to control insect populations that harm health, food security and biodiversity. The Imperial College London startup was founded in 2022 by Imperial researchers in partnership with technology-focused investment group Neurone to create a more effective and sustainable alternative to pesticides.
Here's a selection of featured BIA publications. See Resources Hub
BIA submission to Spring Budget 2023
BIA has submitted its representation to HM Treasury for the Spring Budget 2023.
Ready, Set, Patent? How to get ready for the Unitary Patent and the Unified Patent Court in 2023
UK biotech financing in 2022
The UK’s innovative life sciences and biotech sector secured its fifth best fundraising year ever in 2022, with £1,785 million raised by UK-headquartered public and private companies across the year. While positive, this overall figure masks a mixed picture for the sector.
MMIP Delivering the UK’s Life Sciences Manufacturing Strategy
Pharma looks to UK for innovation as global economic uncertainty hits fundraising
As global macroeconomic uncertainty hit fundraising across all sectors, investment in UK biotech fell from the all-time highs seen in 2021, new analysis from the UK BioIndustry Association (BIA) and data and insights company Clarivate shows. However, global pharma and investors looked to UK innovation to strengthen their product pipelines, with UK biotechs being acquired at a premium and others achieving pivotal milestones in their development.
BIA announces new appointments to the BIA Board
The BioIndustry Association (BIA) is pleased to announce the members who have been elected to its Board of Directors and will begin their work this month. BIA members elect five Board Directors, which includes four Corporate and one Other member. The Board Directors were voted for by the BIA’s membership in the weeks leading up to the AGM in October. These members will join the BIA Board from 1 January 2023, for a three-year term, adding to the considerable industry knowledge that the BIA Board can draw on.
BIA announces Bowel Cancer UK as its Charity Partnership for 2023
We are delighted to announce Bowel Cancer UK as its charity partner for 2023. Bowel cancer is the UK's second biggest cancer killer, claiming more than 16,500 lives a year, which is 45 people every day. The partnership with the BIA and its members across the UK’s life sciences ecosystem will play a pivotal role in raising awareness and knowledge which could have a significant and lasting impact on research and the understanding of this disease.
BIA Chairman appointed UK Government’s Life Sciences Investment Envoy
Dr Dan Mahony, Chair of the UK BioIndustry Association (BIA), has been appointed Life Sciences Investment Envoy by the Secretary of State for Business, Energy and Industrial Strategy. The Envoy will champion the UK life sciences sector to national and international investors to help increase investment in scaling life science companies.
The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.
Explore opportunities to influence, connect and save with the BIA.
Influence |
Connect |
Save |
|
policymakers, ensuring your voice is heard on the matters that are critical to the success of your organisation |
with the UK ecosystem |
money with the BIA Business Solutions purchasing programme, helping you start, grow and deliver world-changing innovation |
